Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma
Clinical trial NCT00671112 · TERMINATED
Trial details
- NCT number
- NCT00671112
- Sponsor
- Brian Hill, MD, PhD
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2015-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.